Fennmore Health Analytics
Monitoring — no action neededHealthcare Technology · Denver, CO
Jun 4 – Aug 13, 2026
11 weeks of telemetry
Fennmore Health Analytics is 42 points below its escalation threshold — execution bandwidth is the strongest theme at 31 against a threshold of 73. Nothing is currently escalated, though 2 themes are still climbing. No board direction is outstanding.
31
Highest signal
of 73 threshold
0
Open escalations
nothing open
86%
Participation
coverage sufficient
0
Board actions
none assigned
What needs attention
2 active themesExecution Bandwidth
9 independent participants · 5 functions
Reported by 9 independent participants across 5 functions, persistent for 3 weeks and rising.
Resource & Capacity
7 independent participants · 4 functions
Reported by 7 independent participants across 4 functions, persistent for 3 weeks and rising.
Organizational radar
all 8 themes scored0
Escalated
0
Developing
8
Quiet
View all eight themesHide view all eight themes
Organizational radar
Fennmore Health Analytics across the eight themes
Every company is scored on the same eight themes, shaded against this program's own escalation threshold — so a quiet row means quiet, not unmeasured.
Confidence = unique reporters of a theme ÷ active participants over the rolling 4-week window. A cell turns red once it crosses its company's escalation threshold.
Board response
No board direction outstanding, and nothing open that needs one.
high growth · held since January 2024 · Denver, CO
Company contextHide company context
- Employees
- 220
- Signal seats
- 35
- 16% enrolled
- Revenue
- $41M ARR
- EBITDA margin
- 6–9%
Investment thesis
Analytics platform for value-based care contracts, underwritten on net revenue retention above 115%.
Known exposures
- ·Retention supported by two very large customers
- ·Burn plan assumes a Series-extension that has not closed
Signal data is PE-exclusive. Portfolio company leadership has no visibility into submissions, themes, or confidence scores.
Beacon detects. Bearing interprets. You decide.